.png){kind=icon}
.png){kind=icon}
Return
The role and therapeutic potential of protein glycosylation in the immune regulation of breast cancer
.png){kind=icon}
PRE
AI
C
H
J
DOI：10.1016/j.bbcan.2026.189603.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• Protein glycosylation is a crucial “molecular switch” that enables breast cancer cells to evade immune surveillance. • Protein glycosylation reshapes the immune microenvironment of breast cancer by dynamically modifying key proteins such as immune checkpoints and antigen presentation. • Sialylation modification has opened up a new direction for the immunotherapy of immune-inactive tumors such as breast cancer.
Keywords:
protein glycosylation
breast cancer
immune regulation
sialylation
immunotherapy
Journal
B
IF:
0
Papers:
105
Citations:
0
Organization
Cited Papers